BioStar Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Versa Vascularversavascular.cominDec 2025 · $27.3M
Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.
HealthtechMedical DevicesSanta Cruz, US
Co-investorsSanta Cruz VentureView VenturesCadence Healthcare VenturesS3 Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.